Results 181 to 190 of about 240,836 (199)

Andexanet Alfa for Bleeding with Factor Xa Inhibitors

New England Journal of Medicine, 2019
Vignesh, Ponnusamy, Ankur, Sinha, Yizhak, Kupfer   +2 more
openaire   +3 more sources

Reversal of Betrixaban-Induced Anticoagulation in Healthy Volunteers By Andexanet Alfa Free

Blood, 2016
Pamela B. Conley, Genmin Lu
exaly  

962: RETHINKING REVERSAL: THE UNDERAPPRECIATED RISK OF THROMBOTIC COMPLICATIONS AFTER ANDEXANET ALFA USE

Critical Care Medicine
N. Hall, Rebecca Walker, Natalie Htet
semanticscholar   +1 more source

Andexanet alfa (Ondexxya®)

2020
Glechner, Anna, Zachariah, Casey
openaire   +1 more source

Andexanet alfa to reverse the anticoagulant activity of factor Xa inhibitors: a review of design, development and potential place in therapy

Journal of Thrombosis and Thrombolysis, 2018
Benilde Cosmi, Michelangelo Sartori
exaly  

Idarucizumab and andexanet alfa may cause death

Reactions weekly

semanticscholar   +1 more source

35: RISK FACTORS FOR THROMBOISCHEMIC COMPLICATIONS AFTER ANDEXANET ALFA REVERSAL OF FACTOR XA INHIBITORS

Critical Care Medicine
P. Bradshaw, Tiffany Shouse, M. Foertsch
semanticscholar   +1 more source

Andexanet alfa/apixaban/rivaroxaban

Reactions Weekly, 2019
openaire   +1 more source

Andexanet alfa for the reversal of anticoagulant activity in patients treated with direct and indirect factor Xa inhibitors

Expert Review of Cardiovascular Therapy, 2017
Charles Michael Gibson, Yazan Daaboul, Gerald Chi   +2 more
exaly  

The use of andexanet alfa for life-threatening hemorrhagic shock in a DOAC-treated patient due to atraumatic splenic rupture and unexpected diagnosis of visceral leishmaniasis.

Minerva Anestesiologica
P. Ruggiano, S. Stefanini, G. Ruggiano, M. Pazzi, Duccio Conti   +4 more
semanticscholar   +1 more source